PortView
First Trust Nasdaq Pharmaceuticals (FTXH) ETF Holdings & Analysis
ETFOther
What FTXH does
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| Merck & Co., Inc. | 7.62% | |
| AbbVie Inc. | 7.05% | |
| Eli Lilly and Company | 6.92% | |
| Johnson & Johnson | 6.87% | |
| Bristol-Myers Squibb Company | 6.75% | |
| Amgen Inc. | 3.56% | |
| Biogen Inc. | 3.54% | |
| Viatris Inc. | 3.50% | |
| Vertex Pharmaceuticals Incorporated | 3.48% | |
| Regeneron Pharmaceuticals, Inc. | 3.33% |
Sector allocation
| Healthcare | 100.00% |
Geographic allocation
| United States | 95.85% |
| Ireland | 3.49% |
| United Kingdom | 0.52% |
| Other | 0.14% |
PortView Portfolio Insights
PortView analyzes how FTXH fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze FTXH in PortView →Related securities
Related stocks
Frequently asked questions
- What does FTXH track?
- FTXH is the First Trust Nasdaq Pharmaceuticals ETF, a Other ETF.
- What is the expense ratio of FTXH?
- Expense ratio data for FTXH is shown on the page when available from our data provider.
- What are the largest holdings in FTXH?
- Top holdings include MRK, ABBV, LLY, JNJ, BMY.
- How can PortView analyze FTXH overlap with other ETFs?
- PortView computes the holdings overlap between FTXH and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.